•  

     

     

     

     

     

     

    INNOVATE.
    COLLABORATE.
    COMMERCIALIZE. 
           

    The 2016 event sold out! Get involved early to attend.

     

     

     

     

  • Visionary keynotes

    Inspiring case studies

    Interactive roundtable discussions

  • Should your name be on the 2017 speaker list?

AS RESISTANCE GROWS, SO DOES THE NEED FOR CHANGE

 

The World Anti-Microbial Resistance Congress USA gathers C-level decision makers from government, funding agencies, pharma, academia, hospitals, labs, and payers to discuss the urgent need for new antibiotics. As international attention continues to turn to the world's growing resistance to antibiotics, the need for new drugs and significant alternatives to existing ones grows as well. International organizations like WHO, which is running an awareness campaign, have begun to take notice and call for action. 

This 2-day conference presents solutions through key notes, case study presentations, expert opinion and roundtable discussions, and invites key influencers such as BARDA, NIH, FDA, grant agencies, pharma and academia, in the AMR discussion. This conference provides a platform for professionals in the antimicrobial resistance industry to answer the call.

 

 

DOWNLOAD PROSPECTUS

" It was a great networking opportunity and a chance to learn about how others are combating AMR. "

-Assistant Director of Development, George Mason University College of Science

  2016 was BIG

 

   70+ Speakers        

America's Antibody Congress USA 2017

READ MORE

70+ Participating Organizations

Exhibit at America's Antibody Congress USA

READ MORE

 150+ Attendees                              

Networking at World Anti-Microbial Resistance Congress USA

READ MORE

 

BUT NEXT YEAR WILL BE BIGGER

What's new in 2017  
 

 

DIAGNOSTICS STREAM

 The focus is shifting toward increasing speed and accuracy of patient diagnosis as a manner of alleviating the general need for antibiotics. With this shift in focus comes a need we've recognized in this space to provide a platform for leaders in the diagnostics and healthcare industries to discuss developments and improvements to help minimize the need for antibiotics and achieve effective diagnosis sooner.

 

STEWARDSHIP STREAM

Stewardship is the effort to prevent this improper use of drugs, aiming for optimizing everything prescription to duration of treatment to administration of treatment. Much like diagnostics, stewardship provides a potential solution to this growing problem alternative to new antibiotic development.

NEW VENUE

We've outgrown the space at our tried and true venue, and we've found a spot that leaves us with room to grow! Next year's venue, The JW Marriott will offer more space and give us the opportunity to make World Anti-Microbial Resistance Congress USA bigger and better than ever!

 

 

 

 

 

 

APPLY TO SPEAK

2016 SPEAKERS INCLUDED

 

  • Rosemarie Aurigemma at World Anti-Microbial Congress US 2016
    Rosemarie Aurigemma
    Chief Biodefense Drug Development Section
    NIAID, NIH
    Mr Stefano Bertuzzi at World Anti-Microbial Congress US 2016
    Mr Stefano Bertuzzi
    Executive Director/CEO
    American Society for Microbiology
  • James Del Rosso at World Anti-Microbial Congress US 2016
    James Del Rosso
    DO, FAOCD, FAAD, ADJ Clinical Professor, (Dermatology)
    Touro University Nevada
    Michael Draper at World Anti-Microbial Congress US 2016
    Michael Draper
    Senior Director, External Science and Partnering
    Sanofi
  • Michael Dudley at World Anti-Microbial Congress US 2016
    Michael Dudley
    Senior VP of Research and Development and CSO
    The Medicines Company
    Barry Eisenstein at World Anti-Microbial Congress US 2016
    Barry Eisenstein
    Distinguished Physician, Antimicrobials
    Merck & Co.
  • Robert Eisinger at World Anti-Microbial Congress US 2016
    Robert Eisinger
    Senior Health Science Policy Advisor, Division of Program Coordination, Planning, and Strategic Initiatives,
    NIH
    Marcos Espinal at World Anti-Microbial Congress US 2016
    Marcos Espinal
    Director, Dept of Communicable Diseases and Health Analysis
    PAHO/WHO
  • Scott Evans at World Anti-Microbial Congress US 2016
    Scott Evans
    Director, Statistical and Data Management Center (SDMC) for the Antibacterial Resistance Leadership Group (ARLG)
    Harvard University
    Tamar Ghosh at World Anti-Microbial Congress US 2016
    Tamar Ghosh
    Lead, Longitude Prize
    Nesta
  • Steven Gilman at World Anti-Microbial Congress US 2016
    Steven Gilman
    Chairman & CEO
    Contrafect Corporation
    Judy Hackett at World Anti-Microbial Congress US 2016
    Judy Hackett
    Project Coordinator, Drive-AB, Global Payer Evidence Director
    AstraZeneca
  • Chris Houchens at World Anti-Microbial Congress US 2016
    Chris Houchens
    PhD, Branch Chief (Acting), Antibacterials Program
    BARDA
    Hasan Jafri at World Anti-Microbial Congress US 2016
    Hasan Jafri
    Sr. Director, Clinical R&D, Infectious Diseases and Vaccines MedImmune, AstraZeneca,Coordinator, COMBACTE
    Innovative Medicines Initiative
  • Anders Karlén at World Anti-Microbial Congress US 2016
    Anders Karlén
    Managing Entity, ENABLE, Professor in Computer-aided Drug Design
    Uppsala University
    Barbara Kerstiens at World Anti-Microbial Congress US 2016
    Barbara Kerstiens
    Deputy Head of Unit, Fighting Infectious Diseases and Advancing Public Health Research and Innovatio
    European Commission
  • Dr Jane Knisely at World Anti-Microbial Congress US 2016
    Dr Jane Knisely
    Program Officer, Bacteriology and Mycology Branch, NIAID
    NIH - NIAID
    Joe Larsen at World Anti-Microbial Congress US 2016
    Joe Larsen
    Acting Deputy Director
    BARDA
  • Frédéric Laurent at World Anti-Microbial Congress US 2016
    Frédéric Laurent
    Professor of Microbiology, National Reference Center on Staphylococcus
    University Hospital, Lyon
    David Mantus at World Anti-Microbial Congress US 2016
    David Mantus
    Chief Development Officer
    Arsanis Inc
  • Anthony McDonnell at World Anti-Microbial Congress US 2016
    Anthony McDonnell
    Head of Economic Research
    Review on Antimicrobial Resistance
    Sumathi Nambiar at World Anti-Microbial Congress US 2016
    Sumathi Nambiar
    Director, Division of Aniti-Infective Products
    FDA
  • Professor Kevin Outterson at World Anti-Microbial Congress US 2016
    Professor Kevin Outterson
    Professor of Health Law, Bioethics and Human Rights
    Boston University School of Law
    Jean Patel at World Anti-Microbial Congress US 2016
    Jean Patel
    Deputy Director, Office of Antimicrobial Resistance
    Center for Disease Control & Prevention
  • Robin Patel at World Anti-Microbial Congress US 2016
    Robin Patel
    Professor of Microbiology and Medicine
    Mayo Clinic
    Edmund Pezalla at World Anti-Microbial Congress US 2016
    Edmund Pezalla
    VP
    Aetna Pharmacy Management
  • Aleks Radovic-Moreno at World Anti-Microbial Congress US 2016
    Aleks Radovic-Moreno
    Senior Associate
    PureTech Health
    Ribhi Shawar at World Anti-Microbial Congress US 2016
    Ribhi Shawar
    Branch Chief, Division of Microbiology
    CDRH OIR FDA
  • Mr Larry Tsai at World Anti-Microbial Congress US 2016
    Mr Larry Tsai
    VP, Clinical Development
    Tetraphase Pharmaceuticals
    Mr Lucas Wiarda at World Anti-Microbial Congress US 2016
    Mr Lucas Wiarda
    Global Marketing Director & Head of Sustainable Antibiotics Program
    DSM Sinochem Pharmaceuticals
  • David Huang at World Anti-Microbial Congress US 2016
    David Huang
    Chief Medical Officer
    Motif Bio
    Dawn O'Connell at World Anti-Microbial Congress US 2016
    Dawn O'Connell
    Deputy Chief of Staff
    United States Department of Health & Human Services
  • Jennifer Auchtung at World Anti-Microbial Congress US 2016
    Jennifer Auchtung
    Asst Professor, Therapeutic Microbiology Laboratory, Dept. of Molecular Virology and Microbiology
    Baylor College of Medicine
    Byron Beeler at World Anti-Microbial Congress US 2016
    Byron Beeler
    Board Member
    Natural MA
  • Dr Debabrata Biswas at World Anti-Microbial Congress US 2016
    Dr Debabrata Biswas
    Assistant Professor
    University of Maryland University College
    Ramiz Boulos at World Anti-Microbial Congress US 2016
    Ramiz Boulos
    CEO
    Boulos & Cooper
  • Dr Nick Conley at World Anti-Microbial Congress US 2016
    Dr Nick Conley
    Chief Executive Officer
    EpiBiome
    Mr David Larwood at World Anti-Microbial Congress US 2016
    Mr David Larwood
    CEO and Founder
    Valley Fever Solutions
  • James Liang at World Anti-Microbial Congress US 2016
    James Liang
    Professor, Dept. of Biomedical Engineering, Chemistry and Biology
    Stevens Institute of Technology
    Randy D Milby at World Anti-Microbial Congress US 2016
    Randy D Milby
    Chief Executive Officer
    CorMedix Inc.
  • Mr Neil Miller at World Anti-Microbial Congress US 2016
    Mr Neil Miller
    Chief Scientific Officer
    Auspherix Ltd
    Mr Steve Parkinson at World Anti-Microbial Congress US 2016
    Mr Steve Parkinson
    President and Chief Executive Officer
    Lakewood-Amedex Inc.
  • Mr Malcolm Thomas at World Anti-Microbial Congress US 2016
    Mr Malcolm Thomas
    COO
    Agile Sciences, Inc.
    Barry Wohl at World Anti-Microbial Congress US 2016
    Barry Wohl
    CBO
    SymbalRx
  • Robert Yancey, Jr. at World Anti-Microbial Congress US 2016
    Robert Yancey, Jr.
    Infectious Diseases Consultant
    Antibiotic Adjuvant, Inc

 

SEE ALL 2016 SPEAKERS

 

Back and Better than Ever: Pitch & Partner
 

 

Present your research to potential investors

This is the opportunity to pitch your new antibiotic or treatment alternative to those who are looking for the next promising developments in fighting AMR.

Antibiotic Development and Stewardship Included

Presentations will be made in the areas of both antibiotic development and stewardship, highlighting the latest advances in both new antibiotics and alternative therapies for drug-resistant infections. 

 

Make the connection

This is the chance to meet the right people who can set your research on the path to development and success. Take the opportunity to display what you've been working on to those who can truly be instrumental in setting development for your antibiotic or therapy in motion.

SUBMIT YOUR ENQUIRY HERE

WHO ATTENDS?

Here's a glimpse of who attended in 2016

 

See who attends World Anti-Microbial Resistance Congress USA

 

FIND OUT MORE

 

" Well organized meeting that covered broad aspects of antibacterial resistance. 
Excellent! "

-- Professor ,Department of Biomedical Engineering, Chemistry and Biology, Stevens Institute of Technology 

 Sponsors & Exhibitors

 

Platinum Sponsor

Biofilm Control at World Anti-Microbial Resistance Congress USA 2017
 

DOWNLOAD SPONSORSHIP BROCHURE

Register Now

THIS CONFERENCE SOLD OUT IN 2016!
Early registration and partner discounts available.
Click below for the full list of ticket options...

 

REGISTER NOW

 

SIGN UP FOR EVENT UPDATES